Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB13464ExperimentalProtein Based Therapies
Ornipressin: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Vasopressin V1a receptor
Resolves to
Clinical / RWD
Targets
What you can answer from here — as of July 07, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Ornipressin, and which of those have an active Phase 3 trial?